What happens if someone refuses vaccination? Ethicists urge clarity on COVID-19 rollout - CTV News | Canada News Media
Connect with us

Business

What happens if someone refuses vaccination? Ethicists urge clarity on COVID-19 rollout – CTV News

Published

 on


TORONTO —
When the first doses of COVID-19 vaccines finally arrive in Canada, the country will need to grapple with a series of difficult questions that ethicists fear we haven’t spent enough time answering.

For example, which groups should get vaccinated after those most vulnerable? How long will it take for everyone to get their shot? And what happens if a person refuses to get vaccinated?

The clock is ticking to address those questions. Pfizer’s vaccine candidate, which is more than 90-per-cent effective according to the company’s preliminary results, could be approved for use in Canada before Christmas, according to Health Canada’s chief medical adviser.

Kerry Bowman, a bioethicist and assistant professor at the University of Toronto’s faculty of medicine, said the lack of clarity on a number of key issues involving Canada’s rollout is “beginning to make people very anxious.”

“Because we don’t really have a clear plan yet. Or if we do, it’s not available and transparent to the majority of Canadians,” Bowman told CTV News.

WHO GETS VACCINATED FIRST?

Federal health authorities have not released a comprehensive list of what order the vaccine will be delivered. For now, four key groups have been given priority to receive the vaccine, according to recommendations from the National Advisory Committee on Immunization.


Those groups include those at risk of severe illness and death (such as the elderly or those with pre-existing conditions), essential workers most likely to transmit the disease (such as health-care workers), those at risk who live in communities that could suffer disproportionate consequences (such as isolated Indigenous communities), and other workers providing services that contribute to “the functioning of society.”

The committee purposefully left those definitions broad so that policy-makers tasked with plotting provincial roll-outs could define them as they see fit.

But after those groups, who comes next?

Research suggests racialized Canadians are at higher risk than white Canadians of having pre-existing conditions that could put them at risk of severe outcomes from COVID-19.

Employers whose businesses have been sidelined due to COVID-19 will also be among those most keen to get vaccinated. A recent Statistics Canada survey suggested that five per cent of businesses were actively considering bankruptcy or closure this fall. Anxieties are running highest among the arts, entertainment and hospitality industries, with nearly 30 per cent worried they’ll need to resort to layoffs, bankruptcy or closure within six months.

Whatever happens, there will inevitably be a period of time in 2021 when the limited supply of vaccines will create a society of haves and have-nots. Those months will be challenging, says Alison Thompson, an ethicist with the University of Toronto.

“This is very concerning because then we have a society that is really a two-tiered society that is based on some kind of biological grounds,” she said.

CAN YOU REFUSE THE VACCINE?

It’s impossible for anyone to be forced to take the COVID-19 vaccine once it’s available. But there could be real-life consequences to refusal.

“People that don’t want the vaccine, we all know, have an absolute right not to have it. I mean, it is their bodies without question,” Bowman said. “But that is an ethical concern because what will likely happen to people within that group is more and more opportunities may slowly be shut off to them.”

For instance, individuals who aren’t vaccinated may miss out on returning to the workplace or could face other restrictions involving group gatherings.

To make matters trickier, the vaccine will not be immediately available for certain groups. Pregnant women and children, who are not involved in clinical trials of the experimental vaccines, will be excluded from vaccination until more clinical trial data is available.

This exemption may be inconvenient, but it’s standard in these sorts of trials for safety reasons, Thompson said.

“Pregnant women are often excluded from clinical trials on many pharmaceutical products, including vaccines, because of the risk to the fetus that she carries and her own health,” she said.

IMMUNITY PASSPORTS?

The idea of “immunity passports” was floated early on in the pandemic as some governments expressed optimism that individuals who’d recovered from COVID-19 and tested positive for virus-fighting antibodies could be given greater freedoms to travel or return to work.

However, the World Health Organization dismissed the idea, saying there wasn’t enough evidence yet on the effectiveness or longevity of immunity through antibodies.

Vaccines may give new attention to the notion of “immunity passports” — a possibility that Thompson said needs to be handled thoughtfully.

“I think we need to think very carefully about how we use people’s immune status to grant them access to employment and travel and things like that,” she said.

WHAT HAPPENS IF SOMEONE SUFFERS SIDE EFFECTS?

All vaccines currently being study are tested for both their effectiveness and safety. Before reaching the general public, Health Canada needs to approve that the vaccine is safe enough for public use. 

Even so, there’s a chance that some individuals could suffer long-term side effects from a COVID-19 vaccine, Bowman said. It’s simply too early to know for certain.

“I have never heard of a vaccine that is 100-per-cent bulletproof safe, and I have no belief that this will be any different.”

However, he added: “It all sounds very good so far.”

In the event that someone suffers negative side effects of the vaccine, some advocates believe they should be financially compensated. At least 19 countries already have programs in place that compensate individuals injured by vaccines, but Canada does not, except for Quebec.

Thompson said it’s time for Canada to consider its own national compensation program.

“There are things we can be doing from the government side, to really help people view (vaccines) as more trustworthy,” she said, pointing to such a program.

CAN YOU CHOOSE WHICH VACCINE YOU WANT?

With several vaccine candidates in the race to be approved first, with Pfizer and Moderna leading the pack, it’s possible that Canada could have several different vaccines on the market in 2021. However, experts told CTVNews.ca last week that there is no health benefit to receiving more than one type of vaccine.

As for personal choice, it’s unlikely that Canadians will have the option to choose which vaccine they want.

“I suspect that choice will not be an issue as the vaccines arrive in Canada. There will be a strategy to roll out vaccination, prioritizing the most vulnerable and front-line workers,” said Dr. Eleanor Fish, an immunology professor at the University of Toronto.

In the face of so many looming questions, Bowman said it’s important to “get this right.”

“So much of vaccine distribution is tied to ethics now,” he said. “It’s going to be a challenge.”

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version